Because incentives for managed care organizations favor cost containment, concerns have been raised that quality of care has suffered, especially for chronically ill people. This study compares utilization rates of managed care and indemnity patients with three chronic conditions, using five years of claims records (1993-97) from private plans and Medicare in one market. Findings show that for all three conditions, managed care patients were more likely to see both primary care physicians and specialists within a year, but less likely to use a hospital emergency department or to be an inpatient. Assuming that patients with these illnesses should see a physician annually and that good primary care reduces the need for emergency and inpatient services, it appears that the patterns of care used by chronically ill managed care patients in this market do not reflect lower quality than that received by similar indemnity patients.
Since financial incentives in managed care favor cost containment, there have been concerns that patients will not receive services they need and that quality of care will suffer, especially for people with long-term chronic conditions (Druss et al. 2000) . One way to examine that issue is to determine to what extent managed care patients receive less care than indemnity patients and than the recommendations under nationally accepted condition-specific standards of care. Despite the importance of such studies, relatively few have been done (Eddy 1998) . This paper presents results for several relevant utilization measures from a data set that includes both managed care and indemnity patients in the same market.
Background
Research results from the studies that have examined quality of care in managed care and indemnity plans have been mixed. In a series of three papers, Miller and Luft summarized findings from studies published in peer-reviewed journals through June 2001 (Miller and Luft 1994 , 2002 . In the 1997 paper, for example, they discussed eight studies showing better quality for health maintenance organizations (HMOs), but another 14 studies in which care in HMOs was similar to, mixed, or worse than care provided by indemnity plans. A more recent study conducted by another group and using survey data continued this pattern of mixed results. Although it found that HMOs increase ambulatory and preventive care but reduce specialist care (Tu, Kemper, and Wong 1999/2000) , it found no differences between HMOs and other types of insurance in hospital use, emergency room visits, or surgeries.
Although the Health Plan Employer Data and Information Set (HEDIS) reports only on managed care plans, it also supports the finding that care is not as good as it could be (NCQA 1999a) . While HEDIS data show that many indicators of managed care quality appear to be improving over time, wide variation on many performance measures across plans in the same region suggests that quality could be better (NCQA 1999b) . Further, self-studies by managed care organizations (MCOs) also show variation in the extent to which patients get needed services, and this is especially true for people with chronic conditions (Newcomer 1998) .
The gross income of managed care plans is determined by their number of subscribers, and their net is what remains after they deliver care. Thus, plans have an incentive to spend as little as possible in discharging their obligation to provide or arrange for care to patients. In particular, plans want to avoid unnecessary use of expensive services, like emergency departments (EDs) and inpatient hospitalization. One method MCOs use to accomplish that goal is to require that patients have a primary care physician (PCP) and that they access non-primary care services through that PCP. Further, plans facilitate patients' use of PCPs by typically requiring only a modest $5 or $10 copayment for each visit, and by paying physicians a fee for each service provided. Thus, managed care patients tend to face a low financial barrier to using PCP services, but a high procedural barrier-in the form of a PCP referral-to using at least some nonprimary care services.
In contrast, patients covered by indemnity plans often face substantial cost sharing. First, they usually pay a deductible of several hundred dollars before the insurance provisions even become available to them (Gabel et al. 2001) . Then, co-insurance amounting to as much as 20% of the bill often is required. These payments are large enough to discourage use of routine services and may lead subscribers, especially those with limited disposable income, to delay using ambulatory services until it is impossible to avoid them. The result may be higher use of emergency services and even hospitalization for conditions that become serious.
Given the financial incentives affecting both MCOs and their patients, a key concern is that managed care patients may fail to obtain necessary services and, thus, have patterns of care reflecting inadequate quality because of underservice. One way to gain insight into the extent to which this phenomenon actually occurs is to compare utilization patterns provided by MCOs to those received under more traditional indemnity plans.
In this study, we compare utilization measures of patients who are in the same market, have one of three chronic conditions and belong to either MCOs or indemnity insurance plans. We chose patients with chronic conditions for three reasons. First, people with chronic illness need and use services and, therefore, tend to have utilization patterns that can be examined. Second, by controlling for disease, we can compare utilization patterns to independently developed norms for people with those conditions. And third, comparisons can be made between similar patients who differ primarily in whether they have managed care or indemnity coverage.
Quality of care is a complex concept, and its many aspects can be indicated with a variety of measures (Eddy 1998; McGlynn 1997; Blumenthal 1996) . It encompasses the extent to which appropriate services are used, the skill with which the services that are used are provided, and their relation to certain clinical outcomes. Our focus is on four common services: visits to PCPs, visits to specialists, visits to hospital EDs, and admissions to hospitals.
We selected visits to PCPs because they are the preferred point of entry into the health care system (Starfield 1998) . Many MCOs require patients to contact their PCPs when they first want to access services so that the PCPs, in addition to providing care directly, can guide their patients to services that are necessary and avoid those that are not. It is, therefore, especially important that patients have easy access to their PCPs. Access to specialists is also important because PCPs may not have enough experience with certain complex chronic conditions to render adequate care without consulting specialists. In addition, certain services indicated for patients with particular conditions-like dilated eye exams for diabetics-require specialists. Finally, patients who do not use office-based services as recommended may need to use EDs or be hospitalized if conditions that might have been cared for on an ambulatory basis deteriorated because of delays in treatment.
For these reasons, the study addresses the following principal research questions:
1. Are managed care patients more likely to see PCPs than are indemnity patients with the same chronic condition? 2. Are managed care patients more likely to see specialists than are indemnity patients? 3. Are managed care patients more likely to use hospital EDs than are indemnity patients? 4. Are managed care patients more likely to be hospitalized for complications of their chronic conditions than are indemnity patients?
In the following pages, we describe the methods used, discuss limitations of the data, present the findings, and finally, draw some conclusions and raise questions for further research.
Methods
This study analyzes five years of claims data, over the period, 1993-97, in a single market. All of the largest indemnity and managed care insurers participated, covering an estimated 90% of the market. The study reports data on a final sample of more than 80,000 patients with three prevalent chronic conditions: asthma, diabetes, and congestive heart failure (CHF). All insurers, whether managed care or indemnity, provided comparable claims data, which were merged into a single data set with similarly encrypted identification numbers to allow for comparisons between the two types of plans.
The Setting
The study data come from a northeastern city with approximately one million people and with substantial managed care penetration. As in most cities, employers arrange for much of the population's health insurance coverage and pay part of the premium. The managed care organizations in the city tend to be of the independent practice association (IPA) variety in which physicians belong to organizations (IPAs) that contract with the MCOs on their behalf. Although both the MCOs and the IPAs are at risk for the cost of care, payments to individual physicians and other providers are made by the MCOs on the basis of claims for services rendered. The city's insured residents are covered by six different plans: a large private indemnity plan; two large private MCOs; Medicare risk plans and Medicare indemnity plans; and Medicaid. The state's Medicaid program is the area's only large third-party payer not included in the study.
The Data and the Measures
The study is based on all records of paid claims from all plans offered by the insurers for the years of analysis. Each insurer encrypted identification numbers according to a common algorithm so that claims records could be merged, and a complete record of services received during the period by enrollees with one of the three chronic conditions was constructed. We present utilization measures for four key services: PCP visits, specialist visits, ED visits, and hospitalizations for complications. Specifically, we report the percentage of people who had a confirmed diagnosis of one of the three chronic conditions and used these services during the calendar year. Results are adjusted for age, gender, and case mix using the ''Diagnostic Cost Group'' (DxCG) methodology described subsequently, and are reported separately for those under and over age 65.
The Study Group
From plan eligibility and claims data, the insurers identified all subscribers who had a diagnosis of one of the three chronic conditions (asthma, diabetes, and congestive heart failure) and had a claim between 1993 and 1997. In each year, of those with one of the study diagnoses, more than 90% were covered for the full year by either a managed care plan or an indemnity plan (see Table 1 ). The numbers of patients grew every year, and those in managed care plans increased more than those with indemnity coverage in all three diagnostic groups and for both age groups.
Year-to-year growth was due to a combination of: a) increases in covered lives; b) subscribers with new diagnoses; c) different survival rates among subscribers with the three conditions; d) subscribers switching from one type of plan to the other; and e) carrying previously diagnosed individuals forward from year to year.
Indemnity and managed care plans were very similar in the distribution of subscribers by gender, but indemnity subscribers were more likely to be over 65 years old and managed care subscribers were more likely to be under 65. We present the results separately for those under 65 and those 65 and over, and adjust them for age, gender, and case mix for both groups. We do this to address potential selection bias in the data. This concern arises because although the people age 65 and older with Medicare coverage had a choice of indemnity or managed care plans, we do not know which people under age 65 had such a choice. It could be that people who had a choice of plans and selected managed care were healthier (or sicker) than those choosing indemnity coverage. If those selecting managed care were healthier (sicker) than those choosing indemnity coverage, then it might be that lower (higher) hospitalization rates and lower (higher) hospital emergency department use were due to the lower (greater) need for such care by managed care enrollees rather than the effects of managed care. By presenting separate results for people under age 65 and those 65 and older, we can compare the results for people who may or may not have had a choice of plan with results for those we know had such a choice. In both groups, we further control for gender, case mix, and health risk. Thus, if the results are consistent across age groups, it seems unlikely that selection bias in the under age 65 group is a significant problem. We also believe that selection bias is likely to be minimal because everyone in the sample had at least one of the three chronic conditions and, therefore, all had some expectation of needing services in a given year. For the analyses presented here, the final sample included 82,752 individuals. For any one year, people were included if they had a known insurance type for the full calendar year (managed care or indemnity), one of the three study diagnoses 1 in the previous year, and claims on at least two dates for services associated with those diagnoses (see Table 2 ; requiring at least two dates of service excludes visits to ''rule out'' the diagnosis in question). Since inclusion required finding the diagnosis on claims in the previous year, and data for 1992 were incomplete, we omit the 1993 results from tables 3 through 6, which report utilization results.
Statistical Analyses
The analytic strategy was to examine differences between chronically ill people with managed care and indemnity coverage each year over the four years, 1994 through 1997, for each of the four utilization measures: PCP visits, specialist visits, ED visits, and hospitalizations.
As noted, patients were excluded from a particular year's analyses if they had overlapping insurance types for any part of the year, switched insurance types during the year, had any gap in their coverage during the year, or did not have a study diagnosis prior to that year. This strategy simplified both the comparisons and the interpretation of results since all patients had the same 12 contiguous months of coverage in a particular insurance type. Since at least 93% of all those with one of the study diagnoses had a full year of coverage in a single plan (see Table 1 ), excluding those with part-year coverage or those who switched plans would not change the results appreciably.
For each of the four medical services, unadjusted proportions of subscribers with any use during the year were calculated separately for those with indemnity insurance and those with managed care. We computed a chi-square statistic to test for statistically significant differences in the proportions. Also, we fit adjusted logistic regression models using a dummy variable for insurance type (indemnity ¼ 0; managed care ¼ 1), comparing the proportion of indemnity (referent) patients to managed care patients using each service at least once during the year. A relative risk above 1.00 reflects higher probability of use of the service among managed care patients compared to indemnity patients; a relative risk below 1.00 reflects lower probability of use by managed care patients. We calculated 95% confidence intervals for these adjusted relative risks. Those intervals that do not include 1.00 are statistically significant at the .05 alpha level and are in boldface in the tables. The adjusted models controlled for age (as a continuous variable), gender, and case mix using the DxCG methodology. DxCG scores use demographics, multiple diagnoses, and prior utilization of both inpatient and ambulatory services recorded on claims to predict Utilization of Services the relative resource use for individuals in a subsequent time period (DxCG 1999; Iezzoni 1997) . Although DxCG models ''originally sought to predict next year's costs for elderly Medicare beneficiaries based on their principal inpatient diagnoses,'' they now consider the full set of medical conditions being treated and estimate concurrent as well as future costs (Shwartz and Ash 1997, p. 395) . Also, ''multiple, interrelated International Classification of Diseases, ninth revision, (ICD-9-CM) diagnosis codes for common conditions are grouped and arrayed in a hierarchy based on expense, and individual patients are assigned to the highest group within each hierarchy'' (Shwartz and Ash 1997, p. 395) .
Limitations
Administrative data collected to facilitate payments for services have several limitations. First, they do not provide a full picture of the clinical phenomenon of quality of care. The data reflect whether services were provided, but not the content of the visit or the skill with which care was provided. Second, only the variables available in the claims and eligibility files can be used in adjusting the logistic regression analysis. Thus, we could adjust for gender and age, but not for other demographic characteristics. And, using the DxCG, we could adjust for severity based on diagnosis and claims, but not on clinical data. The DxCG predicts the relative probability of using services in the future based on patient diagnoses and prior utilization, one determinant of which is severity of illness.
Third, for indemnity patients, some of the utilization that satisfied their deductibles may not be included in the data set. This issue is not a concern here for two main reasons. First, nearly all indemnity patients met the deductible and had paid claims for at least one service during the year. (For 1997, the proportion with no claims ranged from only 1.6% to 4.2%.) This is not surprising given that patients with chronic conditions have a high likelihood of repeat use of physician visits, and ED use and hospitalization are expensive enough that they may absorb the deductible. And second, the outcome reported in the paper is the percentage of eligible people who used a particular service, not the volume of services used. The fact that the relationship between utilization rates and type of plan was similar for the two age groups strengthens our confidence in the results. Even though the over-65 age group faced only a $100 annual deductible for ambulatory services under Medicare and the under-65 age group's deductibles were unknown and might be considerably higher, managed care patients in both age groups were more likely to have visited physicians and less likely to have used EDs or to have been admitted to hospitals. Given that many individual services could trigger the deductible and that such services would be recorded even when the insurer paid only part of the bill, we believe the potential under-reporting is not a large problem in this case, especially for the use of ED services and hospitalization among indemnity patients under Medicare. Nonetheless, it is possible that the magnitude of the differences between managed care and indemnity patients may be somewhat overstated, especially for visits to PCPs.
Finally, since these data were from a single market, we cannot generalize to the nation as a whole.
Results

Are Managed Care Patients More Likely than Indemnity Patients To See Primary Care Physicians?
For all three diagnoses and both age groups, the unadjusted proportion of managed care patients who visited PCPs at least once in a year was higher than that of indemnity patients (Table 3 .) In each of the four study years, 95% or more of managed care patients under age 65 with CHF or diabetes saw a PCP. For those 65 and over, the proportion was somewhat lower. In contrast, indemnity patients with the same conditions were less likely to have seen a PCP during the year often by a margin of 15 to 20 percentage points. For asthma, the proportion with PCP visits was substantially lower for patients with both types of coverage and in both age groups; however, as with the other two conditions, those in managed care were more likely to see a PCP than those with indemnity coverage. When the data were adjusted for age, gender, and health risk using the DxCG, the relative risk of seeing a PCP remained higher for managed care patients than for indemnity patients for both age groups; those results were statistically significant (Table 3) .
Are Managed Care Patients More Likely than Indemnity Patients To See Relevant Specialists?
The use of specialists varied by condition. Thus, relatively small proportions of patients with asthma saw allergists, immunologists, or pulmonologists. Among CHF patients under age 65, on the other hand, between 60% and 70% in managed care and just over 50% with indemnity coverage saw cardiologists; the proportions were lower among the older age group. Although few with diabetes saw endocrinologists, about one-quarter of indemnity patients with diabetes under age 65 and almost 40% of managed care patients saw ophthalmologists in a year. For those age 65 and over, the proportions of diabetes patients with specialist visits were about 15% higher for both insurance types.
Except for the relatively small number of patients in both age groups with asthma who saw pulmonologists, managed care patients were more likely in each year to have any visits with specialists relevant to their diseases than indemnity patients were (Table 4) . Thus, each year asthma patients covered by managed care were more likely to see an allergist or immunologist (though, by declining percentages) than were asthma patients with indemnity coverage. 2 Similarly, CHF patients in managed care plans were substantially more likely than their counterparts in indemnity plans to have seen a cardiologist at least once in a year; diabetes patients were more likely to have seen ophthalmologists and, in most years, endocrinologists, too. In nearly all cases, the adjusted relative risk was statistically significant and consistent with those results.
Are Managed Care Patients More Likely than Indemnity Patients To Use Hospital Emergency Departments?
In Table 5 , we present data on the use of hospital emergency departments among indemnity and managed care patients in both age groups with the three chronic conditions. Although the rates varied by diagnosis, the unadjusted proportion of indemnity patients who visited hospital EDs at least once in a year was higher than that of managed care patients (at the p , .001 level) for all three conditions and both age groups in every year. For asthma and diabetes, statistically significant relative risks adjusted for age, gender, and case mix using the DxCG confirmed that finding. Subscribers with CHF in both types of coverage were more likely to use emergency departments at least once during the year than those with the other conditions; but, as was true with the other diagnoses, the probability of using an ED was greater among indemnity patients than among those enrolled in managed care plans, and the difference was twice as large for patients under age 65 (more than 20 percentage points) than for those 65 and over.
Are Managed Care Patients More Likely than Indemnity Patients To be Hospitalized for Complications of their Chronic Conditions?
To examine the impact of coverage type on hospitalization, we calculated the unadjusted propor-tion of patients in the sample for each diagnosis who were hospitalized at least once in a given year for conditions associated with their underlying chronic illness. Other unrelated diagnoses for hospitalization were excluded because they were less likely to be affected by treatment for the underlying chronic condition. The results, presented in Table 6 , show that for all three conditions, indemnity patients were more likely than managed care patients to be hospitalized for complications of their chronic conditions. Relatively small numbers of patients with asthma were hospitalized in a given year for asthma, bronchitis, or chronic obstructive pulmonary disease (COPD). Nonetheless, in all cases, the unadjusted proportions hospitalized were higher among indemnity patients than among managed care patients, and the differences were statistically significant. When the data were adjusted for age, gender, and case mix using the DxCG, the relative risk was consistent with those results in every case for both age groups and nearly always was statistically significant. Regardless of type of coverage, CHF patients were more likely to be hospitalized for reasons associated with their underlying condition than were patients with asthma. However, the comparisons between those covered by indemnity insurance and managed care were similar to the results for patients with asthma. CHF patients covered by indemnity plans were more likely than those covered by managed care plans to be hospitalized at least once for cardiac edema, anasarca, CHF, or cardiomyopathy. Both the proportions of patients hospitalized and the adjusted relative risks were statistically significant (except for patients 65 and over hospitalized for cardiomyopathy because the managed care numbers were too small to produce stable results).
Finally, diabetes patients were less likely than patients with either of the other two conditions to be hospitalized for reasons associated with their illness. Although the unadjusted proportions of patients hospitalized for foot ulcer, cellulitis, and diabetic ketoacidosis were higher among indemnity than managed care patients, for those 65 and over with diabetic ketoacidosis, the proportions were so small that the model could not distinguish between the two groups. The relative risks were always in the direction of higher hospitalization rates among indemnity patients and were nearly always statistically significant.
Discussion
Overall, for all three chronic conditions, managed care patients-whether under age 65 or 65 and older-were more likely to have had at least one visit per year to both PCPs and specialist physicians, but they were less likely to have visited a hospital ED or to have been admitted to a hospital for reasons associated with their underlying chronic illness. These findings stimulate two questions: What do the results suggest about the appropriateness of care patterns for patients with these chronic illnesses under managed care? And what accounts for these striking differences in utilization rates? 
Patterns of Care and Quality
At the outset, we noted, among other things, that quality includes both the extent to which patients use services that are appropriate to their condition and the skill with which those services are provided. In this paper, we have presented data showing only the probability that certain important services were used during a year. In this context, we believe the patterns of care revealed by the data provide four reasonably sound indicators related to quality. First, the data show with great consistency that patients with indemnity coverage were less likely than those enrolled in managed care plans to visit a PCP in a year. Further, since a very high proportion of managed care patients with CHF and diabetes saw a PCP each year, there is little room for improvement on this measure among those with managed care coverage. On the other hand, about 15% of indemnity patients under age 65 with those conditions and 25% of those 65 and over did not see a PCP, reflecting a substantial deficit. The situation among patients with asthma was similar, except that the proportions of both insurance groups and both age groups seeing a PCP at least once in a year were lower than those for the two other conditions. In addition, in contrast to patients with CHF and diabetes, there was little difference in the percentage of each age group who saw a PCP, except that managed care patients age 65 and over were somewhat more likely than younger patients to have done so.
Second, although it is recommended that patients with diabetes have a dilated eye exam annually (Newcomer 1998) , only a minority of diabetes patients in both insurance groups and both age groups saw an ophthalmologist in a year. This finding suggests that many patients with diabetes may not have their eyes examined for one of the most important side effects of diabetes. While it appears that both groups had a deficit in the proportion with eye exams, it was smaller for patients 65 and older than for patients under age 65, and smaller for managed care patients than for indemnity patients. Thus, the probability is considerably higher that managed care patients had annual dilated eye exams than did indemnity patients.
Although the standards for seeing specialists in connection with the other conditions are not as clear cut as those for ophthalmologists and patients with diabetes, the consistency of the results for patients with asthma and CHF makes it reasonable to assume that managed care patients with those conditions, too, were more likely to have obtained services needed from specialists than those with indemnity coverage.
Third, the use of PCP services should be able to reduce the need for the services of a hospital ED. The higher ED use by indemnity patientssometimes as much as four times highercoupled with their lower rates of PCP use suggest a lower probability of appropriate care patterns for them as compared to managed care patients.
Fourth, good primary care should be able to prevent most of the hospitalizations associated with the conditions studied here, especially asthma and diabetes. Therefore, the higher hospitalization rates for complications of the underlying illnesses are consistent with a conclusion of lower quality in the utilization patterns of patients insured by indemnity plans.
In sum, these data appear to be consistent with the following scenario: patients covered by indemnity plans were less likely to have used needed physician services than managed care patients and to have had greater need both to visit EDs and to have been admitted to hospitals as inpatients. What, if anything, do these utilization measures tell us that is relevant to concerns about the care patterns received? The probability of ever seeing a physician is fundamental to quality because other providers, no matter how they are paid, will have no opportunity to provide care that can be measured against evidence-based standards unless patients visit them. For this reason, we believe the probability of seeing a primary care physician is particularly important. These results suggest that-because they were more likely to have visited a PCPthe chronically ill managed care patients in the study had a greater chance of receiving appropriate patterns of care, and therefore, on these dimensions at least, to have had higher quality of care than indemnity patients.
Differences in Utilization
The most likely explanation for these findings is that the utilization results for all four services reflect the financial incentives faced by both patients and physicians, as described in the ''Background'' section. The consistently higher likelihood of a PCP visit for managed care subscribers with any of three chronic conditions compared to similar patients with indemnity coverage holds for both age groups, and is consistent with the financial incentives associated with the two plan types. Managed care patients face no deductible, and little or no copay for physician visits, while indemnity patients first must satisfy a deductible of several hundred dollars for services used and then also may have to pay coinsurance of 20% of each bill. It is important to note that we speak about the cost-sharing tendencies of managed care plans and indemnity plans in general, instead of about specific provisions of the plans in this study. The reason is that although each plan may write separate health insurance contracts for different employers, all indemnity plans have deductibles and coinsurance, and managed care plans tend to have only small cost-sharing amounts at the point of service.
The findings also showed higher rates of specialist use among managed care patients, which leads to the reasonable conclusion that managed care subscribers were not systematically denied access to specialty services as some have feared. On the other hand, the fact that large numbers of managed care patients with diabetes appear not to be getting dilated eye examinations may mean that managed care plans are not yet maximizing their inherent opportunities to make positive changes to the quality and efficiency of care.
When the elaborate equipment, facilities, or specially trained personnel of hospital emergency departments are not needed for the treatment of presenting conditions, ED use is wasteful and adds unnecessarily to medical expenditures. For that reason, and because it is so expensive, unnecessary ED use is a particular target of riskbearing MCOs. Indeed, prior to the large growth in managed care, much utilization of hospital emergency facilities was for non-emergency conditions. This was because office-based physicians, though more appropriate providers of care, were not always accessible at the times patients wanted to see them and because indemnity insurers often did not pay for routine physician office visits but usually did pay for ED services (Davidson 1978) . Financial incentives associated with managed care were expected to reduce the unnecessary use of emergency departments by rewarding managed care organizations with greater retained revenues for treating nonurgent conditions in physician offices.
Since chronically ill managed care patients were more likely to see community-based physicians, it is reasonable to think they had less need for emergency services and, therefore, lower utilization rates for these services indeed may have been appropriate. This conclusion is especially plausible for patients with diabetes and CHF, since nearly all managed care patients with those conditions saw PCPs each year. Further, higher ED rates by indemnity patients were consistent with their lower use of office-based physicians if one assumes that, as a result, they were not getting treatments that would have kept their condition from progressing to the point that care could no longer be avoided. Then, needing services, they chose an ED as the site for care because the need had become urgent or an office-based physician was not available at off hours.
These conclusions are especially reasonable because in the state in which these MCOs operated, managed care patients had for most of the study period the right by law to use emergency facilities without obtaining PCP permission. So, although it is possible that in some places some managed care patients needing emergency services might be denied them because costconscious PCPs would refuse to give permission, that would not have been the case here. Moreover, given the fact that for two of the three conditions, more than 90% of people with managed care coverage had PCP visits-and their PCP visit rates were higher than those of the plan comparison group-it is reasonable to assume that lower ED rates here do not signify unmet need. Without knowing why ED utilization rates were not higher we cannot be certain that low rates reveal good quality. However, in the present case there appears to be little cause for concern.
Finally, the data show that managed care patients-whether under age 65 or age 65 and older-were less likely to be hospitalized than indemnity patients. Although one might be concerned that managed care patients were more likely to be denied admission to hospitals when they needed it than indemnity patients, the higher probability that they used community-based ambulatory services reduces that concern. In fact, since managed care patients were more likely to see physicians than indemnity patients, they may have used the hospital less for complications of the underlying chronic condition in part because the illness was treated effectively outside the hospital and, therefore, hospitalization was unnecessary. Further, if they did need to be hospitalized, the likelihood is that their physicians would have recognized the need and admitted them. Nonetheless, we must add the same caveat as with emergency services: given the data, it is not possible to say definitively that some managed care patients were not denied admission when needed in order to avoid hospital costs.
Policy Implications
The analyses presented here measure the extent to which patients actually accessed the health care system and, when they did, what portal of entry they used. The points of access are important to the appropriateness of patients' utilization patterns and, therefore, to the quality of care received for two reasons: a primary care physician is the preferred portal to the health care system, and the probability of receiving services that conform to disease-specific evidence-based standards is higher if patients have and use a primary care physician who knows them (Starfield 1998 ). Yet, reasonable as this statement is, further analysis is necessary to compare patients' complete utilization rates and patterns to evidence-based standards and, thereby, test it directly.
Overall, these results do not support the fears that chronically ill managed care patients are systematically disadvantaged because of financial incentives that encourage lower spending on care. In fact, the greater likelihood of using ambulatory services in a year may indicate a higher probability that the patterns of care used by managed care patients were appropriate compared to those of indemnity patients. By itself, the lower likelihood of ED and inpatient hospital services for managed care patients might mean they were not as severely ill as indemnity patients, but that conclusion appears to be inconsistent with both the case-mix adjustments applied to the data and managed care patients' higher use of physician services. Moreover, it applies to both patients under age 65 and those 65 and older.
We believe the explanation that is consistent with all four measures reported here is the impact of financial incentives on both patients and physicians. Indemnity patients face considerable cost sharing, which is consistent with their lower use of physician visits; managed care patients incur either no cost sharing or minimal copayments. Similarly, since physicians are paid fees for the services provided, they have no financial reason to deny services to patients covered by either type of plan. Further, even when the physician's IPA shares the risk with the MCOs, the impact on individual physicians is likely to be so diluted as to have little deterrent effect on particular utilization decisions.
Further research is needed to confirm these results and elaborate on them by answering additional questions. Do the apparent benefits of managed care found in this study to date hold up with a more comprehensive analysis of utilization rates for these same patients? Are they replicated in other markets? Are utilization patterns that reflect appropriate care also less expensive than other common utilization patterns? Is removal of the financial disincentives to seek care from PCPs found in indemnity insurance the primary benefit of managed care? To what extent do managed care organizations introduce affirmative programs that facilitate the delivery of ''best practice'' patterns of care?
The deterrent effect of financial incentives on use of discretionary ambulatory services by indemnity patients is consistent with the results of previous research (Newhouse et al. 1981 ). While it is theoretically possible that the greatest effect of managed care to date is to remove financial barriers to first-contact primary care, we may not be giving managed care its due. The financial arrangements in managed care mean that MCOs would benefit from taking affirmative steps to improve the quality of individual services, the integration of care both within and between episodes of illness, and the efficiency of care. In this context, disease management programs for specific chronic conditions may make sense on both clinical and economic grounds, but they can work only with patients who actually access the system. Future research should examine the extent to which managed care organizations have taken such positive actions to improve care.
Notes
1 The specific criteria were as follows: Asthma-ICD9 codes of 493, 493.9, 493.1, or 493.2 or Generic Product Identifier drug code of 44 in the first two digits; CHF-ICD9 codes of 425.4, 428.x, 398.91, 402.01, 402.11, 402.91, 404.01, 404.11, 404.03, 404.13, 404.93, or 996.83 or digitalis and a diuretic or digitalis and an ACE inhibitor; Diabetes-ICD9 codes of 250, 357.2, 362.0, or 648.0 or GPI drug code of 27 in the first two digits.
2 A qualification to this general pattern concerned the likelihood that asthmatics would see pulmonologists. Unadjusted proportions of indemnity patients who visited a pulmonologist were less than two percentage points higher than managed care patients, but when adjusted for age, gender, and health status, the probability of using pulmonologists did not differ significantly for the two groups.
